• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤代谢亢进导致对免疫治疗产生抵抗。

Tumor hypermetabolism confers resistance to immunotherapy.

机构信息

Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, 77054, USA.

Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, 77054, USA.

出版信息

Semin Cancer Biol. 2020 Oct;65:155-163. doi: 10.1016/j.semcancer.2020.01.009. Epub 2020 Jan 23.

DOI:10.1016/j.semcancer.2020.01.009
PMID:31982512
Abstract

Advances in our understanding of tumor immune biology and development of cancer immunotherapies have led to improved outcomes for patients that suffer from aggressive cancers such as metastatic melanoma. Despite these advances, a significant proportion of patients still fail to benefit, and as a result, attention has shifted to understanding how cancer cells escape immune destruction. Of particular interest is the metabolic landscape of the tumor microenvironment, as recent studies have demonstrated how both competition for essential nutrients and depletion of specific amino acids can promote T cell dysfunction. Here, we will discuss the major energetic pathways engaged by both T cells and cancer cells, metabolic substrates present in the tumor microenvironment, and emerging therapeutic strategies that seek to improve T cell metabolic fitness and bolster the antitumor immune response.

摘要

我们对肿瘤免疫生物学的认识不断提高,癌症免疫疗法也不断发展,这使得患有侵袭性癌症(如转移性黑色素瘤)的患者的预后得到了改善。尽管取得了这些进展,但仍有相当一部分患者未能从中受益,因此,人们的注意力已转向了解癌细胞如何逃避免疫破坏。特别引人关注的是肿瘤微环境的代谢景观,因为最近的研究表明,肿瘤微环境中必需营养物质的竞争和特定氨基酸的消耗如何促进 T 细胞功能障碍。在这里,我们将讨论 T 细胞和癌细胞所涉及的主要能量途径、肿瘤微环境中存在的代谢底物,以及寻求改善 T 细胞代谢适应性和增强抗肿瘤免疫反应的新兴治疗策略。

相似文献

1
Tumor hypermetabolism confers resistance to immunotherapy.肿瘤代谢亢进导致对免疫治疗产生抵抗。
Semin Cancer Biol. 2020 Oct;65:155-163. doi: 10.1016/j.semcancer.2020.01.009. Epub 2020 Jan 23.
2
Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression.获得性癌症免疫疗法耐药性:肿瘤介导免疫抑制的作用。
Semin Cancer Biol. 2020 Oct;65:13-27. doi: 10.1016/j.semcancer.2019.07.017. Epub 2019 Jul 27.
3
Tackling Resistance to Cancer Immunotherapy: What Do We Know?攻克癌症免疫疗法耐药性:我们了解多少?
Molecules. 2020 Sep 8;25(18):4096. doi: 10.3390/molecules25184096.
4
Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy.肿瘤杀伤 T 细胞重编程:改善代谢适应性以增强癌症免疫治疗效果。
Clin Cancer Res. 2018 Jun 1;24(11):2473-2481. doi: 10.1158/1078-0432.CCR-17-0894. Epub 2018 Jan 31.
5
Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor Immunity.靶向肿瘤微环境中的自噬:调控肿瘤免疫的新挑战和新机遇。
Front Immunol. 2018 Apr 25;9:887. doi: 10.3389/fimmu.2018.00887. eCollection 2018.
6
Understanding genetic determinants of resistance to immune checkpoint blockers.理解免疫检查点抑制剂耐药的遗传决定因素。
Semin Cancer Biol. 2020 Oct;65:123-139. doi: 10.1016/j.semcancer.2019.12.020. Epub 2019 Dec 24.
7
Dysfunctional T cell metabolism in the tumor microenvironment.肿瘤微环境中功能失调的T细胞代谢。
Cytokine Growth Factor Rev. 2017 Jun;35:7-14. doi: 10.1016/j.cytogfr.2017.04.003. Epub 2017 Apr 23.
8
Turning up the heat on non-immunoreactive tumours: opportunities for clinical development.加热非免疫反应性肿瘤:临床开发的机会。
Lancet Oncol. 2020 Sep;21(9):e419-e430. doi: 10.1016/S1470-2045(20)30234-5.
9
The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy.肿瘤微环境作为效应 T 细胞和免疫疗法的代谢障碍。
Elife. 2020 May 5;9:e55185. doi: 10.7554/eLife.55185.
10
The tumor organismal environment: Role in tumor development and cancer immunotherapy.肿瘤机体环境:在肿瘤发生和癌症免疫治疗中的作用。
Semin Cancer Biol. 2020 Oct;65:197-206. doi: 10.1016/j.semcancer.2019.12.021. Epub 2019 Dec 28.

引用本文的文献

1
Constructing a novel mitochondrial metabolism-related genes signature to evaluate tumor immune microenvironment and predict survival of colorectal cancer.构建一种新型线粒体代谢相关基因特征以评估肿瘤免疫微环境并预测结直肠癌患者的生存情况。
Front Med (Lausanne). 2025 Jul 8;12:1618471. doi: 10.3389/fmed.2025.1618471. eCollection 2025.
2
Transcriptomic signatures in peripheral CD4T-lymphocytes may reflect melanoma staging and immunotherapy responsiveness prior to ICI initiation.外周血CD4 T淋巴细胞中的转录组特征可能反映黑色素瘤的分期以及在开始免疫检查点抑制剂治疗之前的免疫治疗反应性。
Front Immunol. 2025 Mar 28;16:1529707. doi: 10.3389/fimmu.2025.1529707. eCollection 2025.
3
Current and future therapies for small cell lung carcinoma.
小细胞肺癌的当前及未来治疗方法
J Hematol Oncol. 2025 Apr 1;18(1):37. doi: 10.1186/s13045-025-01690-6.
4
Hepatocellular Carcinoma Immunotherapy: Predictors of Response, Issues, and Challenges.肝细胞癌免疫治疗:反应预测因素、问题与挑战。
Int J Mol Sci. 2024 Oct 15;25(20):11091. doi: 10.3390/ijms252011091.
5
The Effects of Hypoxia on the Immune-Metabolic Interplay in Liver Cancer.缺氧对肝癌免疫代谢相互作用的影响。
Biomolecules. 2024 Aug 17;14(8):1024. doi: 10.3390/biom14081024.
6
Reduced expression of secretogranin VGF in laryngeal squamous cell carcinoma.分泌粒蛋白VGF在喉鳞状细胞癌中的表达降低。
Oncol Lett. 2023 Nov 30;27(1):37. doi: 10.3892/ol.2023.14170. eCollection 2024 Jan.
7
The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy.靶向血红素和线粒体呼吸在使肿瘤微环境正常化及增强免疫治疗方面的前景。
Front Oncol. 2023 Jan 4;12:1072739. doi: 10.3389/fonc.2022.1072739. eCollection 2022.
8
N1-methyladenosine methylation-related metabolic genes signature and subtypes for predicting prognosis and immune microenvironment in osteosarcoma.用于预测骨肉瘤预后和免疫微环境的N1-甲基腺苷甲基化相关代谢基因特征及亚型
Front Genet. 2022 Sep 6;13:993594. doi: 10.3389/fgene.2022.993594. eCollection 2022.
9
Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab.接受纳武单抗治疗的转移性肾细胞癌患者的能量消耗与疗效的关联
Cancers (Basel). 2022 Jun 30;14(13):3214. doi: 10.3390/cancers14133214.
10
Anti-Tumor Effect of IDF-11774, an Inhibitor of Hypoxia-Inducible Factor-1, on Melanoma.缺氧诱导因子-1抑制剂IDF-11774对黑色素瘤的抗肿瘤作用
Biomol Ther (Seoul). 2022 Sep 1;30(5):465-472. doi: 10.4062/biomolther.2022.061. Epub 2022 Jun 17.